Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria

Recruiting Observational Study
HIV Cervical Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
25 – 50
Sex
Female
Study type
Observational
Participants needed
1,500 (estimated)
Sponsor
Emory University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to focus on adapting and implementing a program to promote HPV and cervical cancer (CC) screening and follow-up treatment for HIV-positive women, with three specific aims: * Adaptation: Use stakeholder deliberation to tailor the successful MoMent program for this population. * Implementation and Assessment: Deploy the adapted MoMent program and evaluate its…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: \- Patients must be able to perform vaginal self-collection as well as give informed consent Exclusion Criteria: * Male gender * Age \<25 or \>50 * Unknown or negative HIV status * Pregnancy * Hysterectomy * Inability to give informed consent Inability/refusal to perform vagin…
Contacts

Lisa Flowers, MD, MPH

404-712-3522

Lflowe2@emory.edu

CONTACT